Please try another search
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
AddLife | 108.60 | 108.80 | 105.80 | +1.20 | +1.12% | 60.37K | 01:24:59 | ||
Arjo | 46.96 | 46.98 | 46.00 | +1.18 | +2.58% | 287.59K | 01:24:59 | ||
Bactiguard Holding AB | 69.00 | 71.80 | 67.00 | -2.80 | -3.90% | 4.61K | 01:09:10 | ||
BICO Group | 44.00 | 45.94 | 40.40 | +4.68 | +11.90% | 703.58K | 01:24:58 | ||
Boule Diagnostics | 9.68 | 10.40 | 9.56 | -0.32 | -3.20% | 17.82K | 01:29:43 | ||
C-Rad | 41.05 | 42.20 | 38.30 | +2.80 | +7.32% | 64.46K | 01:24:24 | ||
CellaVision AB | 240.00 | 246.00 | 232.00 | +3.00 | +1.27% | 18.04K | 01:24:30 | ||
Elekta B | 80.70 | 81.00 | 79.60 | +1.50 | +1.89% | 338.16K | 01:24:14 | ||
Episurf Medical AB | 0.42 | 0.43 | 0.38 | +0.02 | +5.41% | 345.36K | 01:29:52 | ||
Getinge B | 210.4 | 219.7 | 208.1 | -22.1 | -9.51% | 2.62M | 01:24:34 | ||
Immunovia publ AB | 1.65 | 1.85 | 1.63 | -0.08 | -4.73% | 386.87K | 01:29:50 | ||
Ortivus A | 4.240 | 4.860 | 4.240 | -0.620 | -12.76% | 2.71K | 10/05 | ||
Ortivus B | 2.540 | 2.570 | 2.470 | +0.010 | +0.40% | 5.12K | 10/05 | ||
Q linea | 2.27 | 2.47 | 2.26 | -0.05 | -2.16% | 189.26K | 01:29:52 | ||
RaySearch Labs B | 132.60 | 133.00 | 127.00 | +5.20 | +4.08% | 69.65K | 01:24:55 | ||
Sectra | 235.80 | 236.40 | 226.40 | +10.20 | +4.52% | 283.38K | 01:29:46 | ||
Sedana Medical | 20.95 | 21.70 | 20.65 | -0.45 | -2.10% | 88.46K | 01:29:42 | ||
Senzime | 6.9900 | 7.0800 | 6.7800 | +0.1100 | +1.60% | 240.92K | 01:29:45 | ||
Vitrolife | 178.30 | 181.00 | 176.50 | +0.10 | +0.06% | 45.04K | 01:29:42 | ||
Xvivo Perfusion AB | 381.00 | 385.00 | 372.50 | -0.50 | -0.13% | 68.57K | 01:24:46 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review